These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 23760674)

  • 1. Antitumor properties of a vanadyl(IV) complex with the flavonoid chrysin [VO(chrysin)2EtOH]2 in a human osteosarcoma model: the role of oxidative stress and apoptosis.
    Leon IE; Di Virgilio AL; Porro V; Muglia CI; Naso LG; Williams PA; Bollati-Fogolin M; Etcheverry SB
    Dalton Trans; 2013 Sep; 42(33):11868-80. PubMed ID: 23760674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deciphering the effect of an oxovanadium(iv) complex with the flavonoid chrysin (VOChrys) on intracellular cell signalling pathways in an osteosarcoma cell line.
    León IE; Díez P; Etcheverry SB; Fuentes M
    Metallomics; 2016 Aug; 8(8):739-49. PubMed ID: 27175625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of oxidative stress in the antitumoral action of a new vanadyl(IV) complex with the flavonoid chrysin in two osteoblast cell lines: relationship with the radical scavenger activity.
    Naso L; Ferrer EG; Lezama L; Rojo T; Etcheverry SB; Williams P
    J Biol Inorg Chem; 2010 Aug; 15(6):889-902. PubMed ID: 20364393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Copper(II) Complexes with Saccharinate and Glutamine as Antitumor Agents: Cytoand Genotoxicity in Human Osteosarcoma Cells.
    Cadavid-Vargas JF; Leon IE; Etcheverry SB; Santi E; Torre MH; Di Virgilio AL
    Anticancer Agents Med Chem; 2017; 17(3):424-433. PubMed ID: 27173967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo antitumor effects of the VO-chrysin complex on a new three-dimensional osteosarcoma spheroids model and a xenograft tumor in mice.
    León IE; Cadavid-Vargas JF; Resasco A; Maschi F; Ayala MA; Carbone C; Etcheverry SB
    J Biol Inorg Chem; 2016 Dec; 21(8):1009-1020. PubMed ID: 27696106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiproliferative and apoptosis-inducing activity of an oxidovanadium(IV) complex with the flavonoid silibinin against osteosarcoma cells.
    Leon IE; Porro V; Di Virgilio AL; Naso LG; Williams PA; Bollati-Fogolín M; Etcheverry SB
    J Biol Inorg Chem; 2014 Jan; 19(1):59-74. PubMed ID: 24233155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polyoxometalates as antitumor agents: Bioactivity of a new polyoxometalate with copper on a human osteosarcoma model.
    León IE; Porro V; Astrada S; Egusquiza MG; Cabello CI; Bollati-Fogolin M; Etcheverry SB
    Chem Biol Interact; 2014 Oct; 222():87-96. PubMed ID: 25451568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidovanadium(IV) complexes with chrysin and silibinin: anticancer activity and mechanisms of action in a human colon adenocarcinoma model.
    León IE; Cadavid-Vargas JF; Tiscornia I; Porro V; Castelli S; Katkar P; Desideri A; Bollati-Fogolin M; Etcheverry SB
    J Biol Inorg Chem; 2015 Oct; 20(7):1175-91. PubMed ID: 26404080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxylamido-amino acid complexes of oxovanadium(V). Toxicological study in cell culture and in a zebrafish model.
    León IE; Di Virgilio AL; Barrio DA; Arrambide G; Gambino D; Etcheverry SB
    Metallomics; 2012 Dec; 4(12):1287-96. PubMed ID: 23073485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antioxidant, DNA cleavage, and cellular effects of silibinin and a new oxovanadium(IV)/silibinin complex.
    Naso LG; Ferrer EG; Butenko N; Cavaco I; Lezama L; Rojo T; Etcheverry SB; Williams PA
    J Biol Inorg Chem; 2011 Apr; 16(4):653-68. PubMed ID: 21399988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bis(4,7-dimethyl-1,10-phenanthroline) sulfatooxovanadium(IV) as a novel apoptosis-inducing anticancer agent.
    Narla RK; Dong Y; D'Cruz OJ; Navara C; Uckun FM
    Clin Cancer Res; 2000 Apr; 6(4):1546-56. PubMed ID: 10778988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological evaluation of morin and its new oxovanadium(IV) complex as antioxidant and specific anti-cancer agents.
    Naso LG; Lezama L; Rojo T; Etcheverry SB; Valcarcel M; Roura M; Salado C; Ferrer EG; Williams PA
    Chem Biol Interact; 2013 Nov; 206(2):289-301. PubMed ID: 24125835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new oxidovanadium(IV) complex of oxodiacetic acid and dppz: spectroscopic and DFT study. Antitumor action on MG-63 human osteosarcoma cell line.
    León IE; Parajón-Costa BS; Franca CA; Etcheverry SB; Baran EJ
    Biol Trace Elem Res; 2015 Apr; 164(2):198-204. PubMed ID: 25534289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vanadium and cancer treatment: antitumoral mechanisms of three oxidovanadium(IV) complexes on a human osteosarcoma cell line.
    León IE; Butenko N; Di Virgilio AL; Muglia CI; Baran EJ; Cavaco I; Etcheverry SB
    J Inorg Biochem; 2014 May; 134():106-17. PubMed ID: 24199985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spectroscopic characterization of an oxovanadium(IV) complex of oxodiacetic acid and o-phenanthroline. Bioactivity on osteoblast-like cells in culture.
    León IE; Etcheverry SB; Parajón-Costa BS; Baran EJ
    Biol Trace Elem Res; 2012 Jun; 147(1-3):403-7. PubMed ID: 22246791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bis(oxalato)dioxovanadate(V) and bis(oxalato)oxoperoxo-vanadate(V) complexes: spectroscopic characterization and biological activity.
    León IE; Etcheverry SB; Parajón-Costa BS; Baran EJ
    Biol Trace Elem Res; 2013 Nov; 155(2):295-300. PubMed ID: 24026441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Palladacycle (BPC) antitumour activity against resistant and metastatic cell lines: the relationship with cytosolic calcium mobilisation and cathepsin B activity.
    Bechara A; Barbosa CM; Paredes-Gamero EJ; Garcia DM; Silva LS; Matsuo AL; Nascimento FD; Rodrigues EG; Caires AC; Smaili SS; Bincoletto C
    Eur J Med Chem; 2014 May; 79():24-33. PubMed ID: 24709226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving the bioactivity of Zn(II)-curcumin based complexes.
    Pucci D; Crispini A; Sanz Mendiguchía B; Pirillo S; Ghedini M; Morelli S; De Bartolo L
    Dalton Trans; 2013 Jul; 42(26):9679-87. PubMed ID: 23680928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, interaction with DNA, cytotoxicity, cell cycle arrest and apoptotic inducing properties of ruthenium(II) molecular "light switch" complexes.
    Shobha Devi C; Anil Kumar D; Singh SS; Gabra N; Deepika N; Kumar YP; Satyanarayana S
    Eur J Med Chem; 2013 Jun; 64():410-21. PubMed ID: 23665797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological evaluation of new nickel(II) metallates: Synthesis, DNA/protein binding and mitochondrial mediated apoptosis in human lung cancer cells (A549) via ROS hypergeneration and depletion of cellular antioxidant pool.
    Kalaivani P; Saranya S; Poornima P; Prabhakaran R; Dallemer F; Vijaya Padma V; Natarajan K
    Eur J Med Chem; 2014 Jul; 82():584-99. PubMed ID: 24946146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.